• Milestone

    Study to evaluate the efficacy, and safety of etripamil nasal spray for the termination of spontaneous episodes of paroxysmal supraventricular tachycardia (RAPID NODE-301).

  • CinCor

    A double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of multiple dose strengths of CIN-107 as compared to placebo after 8 weeks of treatment in patients with uncontrolled hypertension (HALO).

  • AstraZeneca

    A study to assess the efficacy and safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) relative to Budesonide and Formoterol Fumarate MDI and Symbicort® pressurized MDI in adult and adolescent participants with inadequately controlled asthma (LOGOS).

  • Alnylam

    A study to evaluate the efficacy and safety of Zilebesiran, used as add-on therapy in patients with hypertension not adequately controlled by an antihypertensive medication (KARDIA 2).